Potent, high affinity, selective BET bromodomain inhibitor (IC
values are 17.7, 32.6, 76.9 and 12942 nM for BRD2 (N-terminal (N)), BRD4 (C-terminal (C)), BRD4 (N) and CREBBP respectively; K
values are 49, 59.5, 82, 90.1, 128 and 190 nM for BRD4 (N), BRD3 (N), BRD3 (C), BRD4 (C), BRD2 (N) and BRDT (N) respectively). Induces squamous differentiation in NUT midline carcinoma (NMC) cell lines; inhibits tumor growth in NMC xenograft models
. Exhibits reversible contraceptive effects in germ cells from male mice. Inactive analog
External Portal Information
is a portal that offers independent guidance on the selection and/or application of small molecules for research. The use of
is reviewed on the chemical probes website.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
This probe is supplied in conjunction with the Structural Genomics Consortium. For further characterization details, please visit the
(+)-JQ1 probe summary
on the SGC website.
Other Product-Specific Information:
Small-molecule inhibition of BRDT for male contraception.
Matzuk et al.
Selective inhibition of BET bromodomains.
Filippakopoulos et al.
Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
Herrmann et al.
Oncotarget. [Epub ahead of print], 2012;3:1588
The citations listed below are publications that use Tocris products. Selected citations for (+)-JQ1 include:
1 Citations: Showing 1 - 1
Have you used (+)-JQ1?
Submit a Review
Submit a review and receive a $25US/€18/£15/$25CAN amazon gift card if you include an image - $10US/€7/£6/$10CAN Amazon card for reviews without an image. Limited to verified customers in USA, Canada and Europe.